News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Navidea Biopharmaceuticals (NEOP) to Present at the JMP Securities Healthcare Conference



7/9/2012 9:49:06 AM

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today announced that Dr. Mark Pykett, Navidea’s President and Chief Executive Officer, will participate at the JMP Securities Healthcare Conference on July 12-13, 2012 at the Peninsula Hotel in New York City. Dr. Pykett will provide an update of the Company and its development programs on Thursday, July 12, 2012 at 12:30 PM EDT.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES